A new cancer vaccine for advanced melanoma patients is being fast-tracked through the NHS in England, offering fresh hope to those battling this serious form of skin cancer. The vaccine, called iSCIB1+ (Immunobody), developed by UK-based Scancell, works differently from preventative vaccines. It helps the body’s immune system better recognize, attack and “remember” cancer cells, potentially stopping the disease from returning. NHS England has expanded its world-first Cancer Vaccine Launch Pad (CVLP) program to include this melanoma vaccine trial. Seven hospital sites are initially registered to offer the treatment, with patient referrals expected to begin next month. “Skin cancer can … Continue reading Melanoma Vaccine Trial Fast-Tracked by NHS After 33% Surge in UK Cases Since 2009